Markets:

Overview

News

Currencies

International

Treasuries

Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

14.07 -0.28 (-1.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Vyant Bio Inc. (NASDAQ: VYNT): Leading a New Biotech Move to Combat Diseases Affecting the Nervous System ↗

October 04, 2022

Biotechnology companies such as Biogen Inc. (NASDAQ: BIIB), Alector Inc.

Via Benzinga

Where Amylyx Pharma Stands With Analysts ↗

October 03, 2022

Analysts have provided the following ratings for Amylyx Pharma (NASDAQ:AMLX) within the last quarter:

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

4 Analysts Have This to Say About Amylyx Pharma ↗

September 08, 2022

Analysts have provided the following ratings for Amylyx Pharma (NASDAQ:AMLX) within the last quarter:

Via Benzinga

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗

October 02, 2022

Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

After Initial Skepticism FDA's Adcomm Backs Amylyx's Amyotrophic Lateral Sclerosis Hopeful ↗

September 08, 2022

Via Benzinga

Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 70% Today? ↗

September 08, 2022

Amylyx Pharmaceuticals (AMLX) stock is rocketing higher on Thursday following an update from the FDA on its ALS treatment.

Via InvestorPlace

FDA Again Highlights Lacking Data From Amylyx's Amyotrophic Lateral Sclerosis Candidate ↗

September 06, 2022

Via Benzinga

Bounce In Futures Fizzles As Dollar Surge Returns ↗

September 30, 2022

In premarket trading, Nike shares fall 10% after the sportswear giant cut its margin outlook for the year while reporting surging inventory, fueling worries over consumers’ ability to spend as...

Via Talk Markets

Why Is IONQ Stock Up 8% Today? ↗

September 30, 2022

IonQ (IONQ) stock is climbing higher on Friday after the company announced it secured a $13.4 million contract with the AFRL.

Via InvestorPlace

AMLX Stock Alert: Amylyx Pharma Gains on Huge FDA Win ↗

September 30, 2022

Shares of Amylyx Pharma are popping today on news that the FDA has greenlit its treatment against the deadly disease ALS.

Via InvestorPlace

Why Amylyx Pharmaceuticals Is Trading Higher By Over 8%; Here Are 22 Stocks Moving Premarket ↗

September 30, 2022

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) rose 42% to $3.21 in pre-market trading after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining...

Via Benzinga

The FDA's Mixed Messages Sent Amylyx Pharmaceuticals Stock Off A Cliff ↗

September 02, 2022

The FDA's advisors will meet Wednesday to discuss the experimental ALS treatment.

Via Investor's Business Daily

Why IPO Stock Amylyx Pharmaceuticals Is Beginning To Heat Up — Again ↗

July 05, 2022

Could this FDA action turn things around for Amylyx in September?

Via Investor's Business Daily

IPO Scorcher Amylyx Wins FDA Approval In ALS Treatment, Ending A Long Battle ↗

September 29, 2022

The drug has faced two advisory committees and a delayed review date.

Via Investor's Business Daily

Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test ↗

September 29, 2022

Patients didn't show any improvements in a study meant to test multiple drugs.

Via Investor's Business Daily

Amylyx Pharmaceuticals Stock Sees Relative Strength Rating Rise To 98 ↗

September 09, 2022

Amylyx Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating improve to 98, up from 83 the day before.

Via Investor's Business Daily

US Stocks Flat, Crude Oil Rises 2% ↗

September 08, 2022

U.S. stocks traded almost flat in volatile trading on Thursday following the release of jobless claims data.

Via Benzinga

US Stocks Turn Higher, Nasdaq Jumps 100 Points ↗

September 08, 2022

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.

Via Benzinga

AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday ↗

September 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

AAPL Stock Alert: 13 Takeaways From the Latest Apple Event 2022 ↗

September 08, 2022

Apple (AAPL) stock is a hot topic on Thursday following the tech giant's latest event showing off new products and we've got the details!

Via InvestorPlace

Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

September 08, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

Via Benzinga

Dow Drops 100 Points; US Jobless Claims Fall Further Last Week ↗

September 08, 2022

U.S. stocks traded mostly lower this morning, with the Dow Jones dropping 100 points on Thursday.

Via Benzinga

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗

August 31, 2022

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Via Benzinga

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

These names are benefitting from M&A, clinical data and promising regulatory actions.

Via Investor's Business Daily

7 Biotech Stocks to Buy for Q3 ↗

July 18, 2022

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.

Via InvestorPlace

Why Is Novavax (NVAX) Stock Rallying Today? ↗

July 05, 2022

Novavax (NVAX) stock is taking off on Tuesday after the vaccine company got approval for the expanded use of its Covid-19 vaccine in Europe.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today